Edesa Biotech logo

Edesa Biotech Share Price Today

(NASDAQ: EDSA)

Edesa Biotech share price is $2.27 & ₹197.42 as on 6 Mar 2025, 2.30 'hrs' IST

$2.27

0.12

(5.58%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Edesa Biotech share price in Dollar and Rupees. Guide to invest in Edesa Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Edesa Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Edesa Biotech share price movements

  • Today's Low: $2.11
    Today's High: $2.47

    Day's Volatility :14.48%

  • 52 Weeks Low: $1.55
    52 Weeks High: $5.59

    52 Weeks Volatility :72.27%

Edesa Biotech (EDSA) Returns

PeriodEdesa Biotech IncIndex (Russel 2000)
3 Months
7.58%
0.0%
6 Months
-47.82%
0.0%
1 Year
-47.39%
0.0%
3 Years
-88.34%
-11.6%

Edesa Biotech (EDSA) Key Statistics

in dollars & INR

Previous Close
$2.15
Open
$2.11
Today's High
$2.4674
Today's Low
$2.11
Market Capitalization
$14.9M
Today's Volume
$197.5K
52 Week High
$5.59
52 Week Low
$1.55
Revenue TTM
$500.0
EBITDA
$-6.9M
Earnings Per Share (EPS)
$-1.95
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-150.67%

How to invest in Edesa Biotech Stock (EDSA) from India?

It is very easy for Indian residents to invest directly in Edesa Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Edesa Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Edesa Biotech or EDSA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Edesa Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Edesa Biotech shares which would translate to 0.383 fractional shares of Edesa Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Edesa Biotech, in just a few clicks!

Returns in Edesa Biotech (EDSA) for Indian investors in Rupees

The Edesa Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edesa Biotech investment value today

Current value as on today

₹57,495

Returns

₹42,505

(-42.5%)

Returns from Edesa Biotech Stock

₹47,454 (-47.45%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Edesa Biotech (EDSA)

1450.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Edesa Biotech Shares from India has grown by 1450.0% over the past 30 days, indicating increased transactional activity.

714%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Edesa Biotech Stock from India on INDmoney has increased by 714% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Edesa Biotech

  • CM Management, LLC

    1.59%

  • Citadel Advisors Llc

    0.59%

  • Geode Capital Management, LLC

    0.29%

  • Vanguard Group Inc

    0.23%

  • TWO SIGMA SECURITIES, LLC

    0.22%

  • Tower Research Capital LLC

    0.05%

Analyst Recommendation on Edesa Biotech

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Edesa Biotech(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Edesa Biotech Stock (EDSA)

What analysts predicted

Upside of 781.06%

Target:

$20.00

Current:

$2.27

Insights on Edesa Biotech Stock (Ticker Symbol: EDSA)

  • Price Movement

    In the last 7 days, EDSA stock has moved up by 6.1%
  • EDSA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 113.9%
  • EDSA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 141.5%

Edesa Biotech Technicals Summary

Sell

Neutral

Buy

Edesa Biotech is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Edesa Biotech (EDSA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Edesa Biotech Inc logo
16.57%
-47.82%
-47.39%
-88.34%
-86.32%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Edesa Biotech Inc logo
NA
NA
NA
0.0
-1.51
-0.74
NA
0.37
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Edesa Biotech Inc logo
Buy
$14.9M
-86.32%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Edesa Biotech

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.
Organization
Edesa Biotech
Employees
16
CEO
Dr. Pardeep Nijhawan FRCPC, M.D.
Industry
Biotechnology

Management People of Edesa Biotech

NameTitle
Dr. Pardeep Nijhawan FRCPC, M.D.
CEO, Company Secretary & Director
Dr. Michael J. Brooks M.B.A., Ph.D.
President
Mr. Stephen L. Lemieux BA, CPA, CA, CPA, MMPA
Chief Financial Officer

Important FAQs about investing in EDSA Stock from India :

What is Edesa Biotech share price today?

Edesa Biotech share price today stands at $2.27, Open: $2.11 ; Previous Close: $2.15 ; High: $2.47 ; Low: $2.11 ; 52 Week High: $5.59 ; 52 Week Low: $1.55.

The stock opens at $2.11, after a previous close of $2.15. The stock reached a daily high of $2.47 and a low of $2.11, with a 52-week high of $5.59 and a 52-week low of $1.55.

Can Indians buy Edesa Biotech shares?

Yes, Indians can invest in the Edesa Biotech (EDSA) from India.

With INDmoney, you can buy Edesa Biotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Edesa Biotech at zero transaction cost.

How can I buy Edesa Biotech shares from India?

It is very easy to buy Edesa Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Edesa Biotech (EDSA) be purchased?

Yes, you can buy fractional shares of Edesa Biotech with INDmoney app.

What are the documents required to start investing in Edesa Biotech stocks?

To start investing in Edesa Biotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Edesa Biotech Stock (EDSA)?

Today’s highest price of Edesa Biotech (EDSA) is $2.47.

Today’s lowest price of Edesa Biotech (EDSA) is $2.11.

What is today's market capitalisation of Edesa Biotech?

Today's market capitalisation of Edesa Biotech EDSA is 14.9M

What is the 52 Week High and Low Range of Edesa Biotech Stock (EDSA)?

  • 52 Week High

    $5.59

  • 52 Week Low

    $1.55

What are the historical returns of Edesa Biotech (EDSA)?

  • 1 Month Returns

    16.57%

  • 3 Months Returns

    -47.82%

  • 1 Year Returns

    -47.39%

  • 5 Years Returns

    -86.32%

Who is the Chief Executive Officer (CEO) of Edesa Biotech ?

Dr. Pardeep Nijhawan FRCPC, M.D. is the current Chief Executive Officer (CEO) of Edesa Biotech.